- Home
- PEPG vs CLST Comparison
PEPG vs CLST Comparison
Compare PEPG & CLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- CLST
- Stock Information
- Founded
- PEPG 2018
- CLST 1922
- Country
- PEPG United States
- CLST United States
- Employees
- PEPG N/A
- CLST N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- CLST
- Sector
- PEPG Health Care
- CLST
- Exchange
- PEPG Nasdaq
- CLST Nasdaq
- Market Cap
- PEPG 45.5M
- CLST 51.9M
- IPO Year
- PEPG 2022
- CLST N/A
- Fundamental
- Price
- PEPG $1.22
- CLST $12.70
- Analyst Decision
- PEPG Buy
- CLST
- Analyst Count
- PEPG 3
- CLST 0
- Target Price
- PEPG $7.67
- CLST N/A
- AVG Volume (30 Days)
- PEPG 290.3K
- CLST 17.4K
- Earning Date
- PEPG 08-07-2025
- CLST 07-30-2025
- Dividend Yield
- PEPG N/A
- CLST N/A
- EPS Growth
- PEPG N/A
- CLST N/A
- EPS
- PEPG N/A
- CLST 0.57
- Revenue
- PEPG N/A
- CLST $11,257,000.00
- Revenue This Year
- PEPG N/A
- CLST N/A
- Revenue Next Year
- PEPG N/A
- CLST N/A
- P/E Ratio
- PEPG N/A
- CLST $22.38
- Revenue Growth
- PEPG N/A
- CLST 200.91
- 52 Week Low
- PEPG $0.88
- CLST $10.67
- 52 Week High
- PEPG $19.30
- CLST $14.23
- Technical
- Relative Strength Index (RSI)
- PEPG 41.13
- CLST 65.56
- Support Level
- PEPG $1.05
- CLST $12.10
- Resistance Level
- PEPG $1.49
- CLST $14.23
- Average True Range (ATR)
- PEPG 0.10
- CLST 0.37
- MACD
- PEPG -0.02
- CLST 0.01
- Stochastic Oscillator
- PEPG 38.64
- CLST 34.66
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.